These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3283198)

  • 21. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia.
    Chibnall JT; Tait RC; Harman B; Luebbert RA
    J Am Geriatr Soc; 2005 Nov; 53(11):1921-9. PubMed ID: 16274373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eight-Year Trends in the Use of Opioids, Other Analgesics, and Psychotropic Medications Among Institutionalized Older People in Finland.
    Pitkala KH; Juola AL; Hosia H; Teramura-Gronblad M; Soini H; Savikko N; Bell JS
    J Am Med Dir Assoc; 2015 Nov; 16(11):973-8. PubMed ID: 26170037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discontinuation of a psychogeriatric program for nursing home residents: psychotropic medication changes and behavioral reactions.
    Fitz D; Mallya A
    J Appl Gerontol; 1992 Mar; 11(1):50-63. PubMed ID: 10116945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of the 1987 federal regulations on the use of psychotropic drugs in Minnesota nursing homes.
    Garrard J; Chen V; Dowd B
    Am J Public Health; 1995 Jun; 85(6):771-6. PubMed ID: 7762708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in psychotropic drug use in nursing homes.
    Castle NG
    J Health Soc Policy; 1998; 10(3):13-36. PubMed ID: 10185054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education.
    Ray WA; Taylor JA; Meador KG; Lichtenstein MJ; Griffin MR; Fought R; Adams ML; Blazer DG
    Arch Intern Med; 1993 Mar; 153(6):713-21. PubMed ID: 8447709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychoactive medication use in intermediate-care facility residents.
    Beers M; Avorn J; Soumerai SB; Everitt DE; Sherman DS; Salem S
    JAMA; 1988 Nov; 260(20):3016-20. PubMed ID: 2903260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gerontopsychiatric competence is in demand. The current psychopharmacologic treatment practice in homes for the aged and nursing homes].
    Riedel-Heller SG; Stelzner G; Schork A; Angermeyer MC
    Psychiatr Prax; 1999 Nov; 26(6):273-6. PubMed ID: 10627955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescribing psychoactive medications in nursing homes: current practice in Singapore.
    Mamun K; Goh-Tan CY; Ng LL
    Singapore Med J; 2003 Dec; 44(12):625-9. PubMed ID: 14770256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychotropic medication patterns among youth in foster care.
    Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
    Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychotropic medication use and association with physical and psychosocial outcomes in nursing home residents.
    Galik E; Resnick B
    J Psychiatr Ment Health Nurs; 2013 Apr; 20(3):244-52. PubMed ID: 22500725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status.
    Holmquist IB; Svensson B; Höglund P
    Eur J Clin Pharmacol; 2003 Nov; 59(8-9):669-76. PubMed ID: 14517706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotropic drug use in Sydney nursing homes.
    Snowdon J; Vaughan R; Miller R; Burgess EE; Tremlett P
    Med J Aust; 1995 Jul; 163(2):70-2. PubMed ID: 7616901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations.
    Garrard J; Makris L; Dunham T; Heston LL; Cooper S; Ratner ER; Zelterman D; Kane RL
    JAMA; 1991 Jan 23-30; 265(4):463-7. PubMed ID: 1670645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescribing of psychotropic drugs and indicators for use in residential aged care and residents with dementia.
    Brimelow RE; Wollin JA; Byrne GJ; Dissanayaka NN
    Int Psychogeriatr; 2019 Jun; 31(6):837-847. PubMed ID: 30457077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study.
    Cohen-Mansfield J; Lipson S; Werner P; Billig N; Taylor L; Woosley R
    Arch Intern Med; 1999 Aug 9-23; 159(15):1733-40. PubMed ID: 10448776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries.
    Snowdon J; Galanos D; Vaswani D
    Int Psychogeriatr; 2011 Nov; 23(9):1520-5. PubMed ID: 21429281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in the treatment culture of nursing homes and responses to regulations to reduce drug use.
    Svarstad BL; Mount JK; Bigelow W
    Psychiatr Serv; 2001 May; 52(5):666-72. PubMed ID: 11331803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of psychotropic medication in Tasmanian residential aged care facilities.
    Westbury J; Beld K; Jackson S; Peterson G
    Australas J Ageing; 2010 Jun; 29(2):72-6. PubMed ID: 20553537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.